作者
Amanda J Abraham, Christina M Andrews, Samantha J Harris, Peter D Friedmann
发表日期
2020/1/1
来源
Neurotherapeutics
卷号
17
期号
1
页码范围
55-69
出版商
Elsevier
简介
Despite high mortality rates due to opioid overdose and excessive alcohol consumption, medications for the treatment of alcohol and opioid use disorder have not been widely used in the USA. This paper provides an overview of the literature on the availability of alcohol and opioid used disorder medications in the specialty substance use disorder treatment system, other treatment settings and systems, and among providers with a federal waiver to prescribe buprenorphine. We also present the most current data on the availability of alcohol and opioid use disorder medications in the USA. These estimates show steady growth in availability of opioid use disorder medications over the past decade and a decline in availability of alcohol use disorder medications. However, overall use of medications in the USA remains low. In 2017, only 16.3% of specialty treatment programs offered any single medication for alcohol …
引用总数
2020202120222023202461324235
学术搜索中的文章